SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001062993-24-006906
Filing Date
2024-03-21
Accepted
2024-03-21 08:00:18
Documents
9
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A formdef14a.htm DEF 14A 483682
2 GRAPHIC formdef14axm001.jpg GRAPHIC 2946
3 GRAPHIC formdef14axm002.jpg GRAPHIC 824
4 GRAPHIC formdef14axm003.jpg GRAPHIC 824
5 GRAPHIC formdef14axm004.jpg GRAPHIC 824
6 GRAPHIC formdef14axm005.jpg GRAPHIC 886
7 GRAPHIC formdef14axm006.jpg GRAPHIC 861
8 GRAPHIC formdef14axu001.jpg GRAPHIC 29114
9 GRAPHIC formdef14axu002.jpg GRAPHIC 27764
  Complete submission text file 0001062993-24-006906.txt   574182
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-31187 | Film No.: 24769518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)